1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Oramed Pharmaceuticals Inc (ORMP)
  7. News


Oramed Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Oramed Pharmaceuticals Inc ORMP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.27 1.2% 22.75 17:39:10
Open Price Low Price High Price Close Price Prev Close
22.67 22.39 23.28 22.74 22.48
more quote information »

Recent News

Date Time Source Heading
10/19/20219:30IHNWFeaturedConsolidated Uranium Announces Proposed Spin-Out of Labrador Uranium Inc., Creating a New Labrador Focused Uranium Explorer and Developer
10/19/20218:00IHNWFeaturedMax Resource Assays 3.3% Copper Over 15 Metres at the CONEJO Zone, CESAR North, NE Colombia
10/19/20217:07IHNWFeaturedPharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products
10/15/202117:16EDGARAnnual Statement of Changes in Beneficial Ownership (5)
9/23/202108:25PRNUSOramed to Present at Cantor Fitzgerald Virtual Global..
9/20/202116:01EDGARStatement of Changes in Beneficial Ownership (4)
9/15/202108:10PRNUSOramed's Phase 2 Oral Insulin NASH Trial Reaches Over 50%..
9/09/202108:25PRNUSOramed to Present at H.C. Wainwright 23rd Annual Global..
9/02/202116:50EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
9/02/202116:49EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202116:44EDGARStatement of Changes in Beneficial Ownership (4)
9/01/202108:26EDGARCurrent Report Filing (8-k)
9/01/202108:17EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/31/202116:16EDGARCurrent Report Filing (8-k)
8/24/202108:25PRNUSOramed Reaches 25% Enrollment in Its Second of Two..
8/16/202108:25PRNUSOramed Announces Publication of Oral Insulin Study in..
8/13/202117:06EDGARProspectus Filed Pursuant to Rule 424(b)(7) (424b7)
8/11/202117:16EDGARStatement of Changes in Beneficial Ownership (4)
8/11/202117:15EDGARStatement of Changes in Beneficial Ownership (4)
8/09/202108:40PRNUSOramed to Present at Canaccord Genuity's 41st Annual Growth..
8/06/202116:02EDGARStatement of Changes in Beneficial Ownership (4)
8/05/202107:02EDGARCurrent Report Filing (8-k)
8/05/202106:40PRNUSOravax to Present Keynote Talk on Oral COVID-19 Vaccine at..
8/04/202116:31EDGARInitial Statement of Beneficial Ownership (3)
8/02/202116:31EDGARCurrent Report Filing (8-k)
7/29/202108:31SEEKOramed Pharmaceuticals names chief commercial officer
7/29/202108:25PRNUSOramed Pharmaceuticals Appoints Chief Commercial Officer
7/28/202116:31EDGARProxy Statement (definitive) (def 14a)
7/27/202106:04EDGARNotice of Effectiveness (effect)
7/21/202109:28SEEKOramed subsidiary to start clinical trials for its oral..
7/21/202108:25PRNUSOramed Provides Update on Oravax: Oral Vaccine Maker Gets..
7/16/202116:16EDGARProxy Statement - Notice of Shareholders Meeting..
7/15/202117:07EDGARSecurities Registration Statement (simplified Form) (s-3)
7/15/202116:16EDGARCurrent Report Filing (8-k)
7/14/202116:32EDGARQuarterly Report (10-q)
7/08/202116:30EDGARInitial Statement of Beneficial Ownership (3)
6/22/202108:50SEEKOramed Pharmaceuticals to join Russell 2000 and 3000 Index
6/22/202108:40PRNUSOramed Pharmaceuticals to Join Russell 2000® and Russell..
6/16/202116:09EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/16/202109:37EDGARRegistration of Additional Securities (up to 20%) (s-3mef)
6/08/202108:10PRNUSOramed Reaches 50% Enrollment in Phase 3 Oral Insulin Study
5/25/202116:06EDGARCurrent Report Filing (8-k)
5/25/202108:40PRNUSOramed Issues Letter to Shareholders with Updates on Oral..
5/10/202116:16EDGARCurrent Report Filing (8-k)
4/21/202107:25PRNUSOramed Pharmaceuticals and Oravax Medical to be Featured in..
4/20/202115:59SEEKOramed Pharma initiated buy at Cantor citing the potential..
4/13/202116:20EDGARQuarterly Report (10-q)
3/23/202109:39SEEKOramed initiates second phase 3 study of oral insulin..
3/23/202108:51PRNUSOramed Initiates Second Phase 3 Oral Insulin Study Under the..
3/23/202108:23SEEKORMP, MOGO, LIZI and LEAF among premarket gainers
3/23/202107:37EDGARCurrent Report Filing (8-k)
3/22/202103:06BWPremas Biotech et Oramed annoncent un vaccin candidat oral..
3/19/202110:30BWPremas Biotech and Oramed Announce Oral COVID-19 Vaccine..
See more news about this stock »

Your Recent History
Oramed Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.